| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |